Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07270601 Sponsor: ContextVision AB Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT07270601
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have a liver condition or are at risk:

  • You are between 18 and 75 years old
  • You are willing to give your consent to take part in the study
  • You have been diagnosed with or are suspected to have a fatty liver condition (called MASLD) by a liver specialist, OR you have at least one of the following health conditions: diabetes, obesity (BMI of 25 or above), high cholesterol, or high blood pressure

If you are a healthy volunteer:

  • You are between 18 and 75 years old
  • You are willing to give your consent to take part in the study
  • You have no signs of fatty liver disease based on blood tests, scans, or a doctor's examination
  • You do not have any known pre-existing conditions such as metabolic syndrome, diabetes, obesity, insulin resistance, or abnormal cholesterol levels

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You are unable to have an MRI scan, for example due to severe fear of enclosed spaces, a pacemaker, or metal or mechanical implants in your body
  • You have a current illness or difficulty with thinking and understanding that would prevent you from following breathing instructions during the MRI or ultrasound scan
  • Your BMI is above 35
  • You have a history of drinking more than a certain amount of alcohol regularly, or using drugs, within the past 2 years (confirm with trial site for exact amounts)
  • You have been diagnosed with hepatitis (short-term or long-term) or any other known liver disease
  • You have a known structural abnormality of the liver that you were born with
  • You have known severe scarring of the liver (cirrhosis)
  • You have a known active cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 206-616-0397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ContextVision AB
Registry
ClinicalTrials.gov
Start date
17 November 2025
Est. completion
31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Multiparametric Ultrasound Biomarker vs. MR-PDFF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov